2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

[1]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[2]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[3]  Sankey V. Williams,et al.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass , 2012, Journal of the American College of Cardiology.

[4]  苅尾 七臣,et al.  ガイドライン解説 AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease : 2011 update , 2012 .

[5]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[6]  M. Link,et al.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. , 2012, Circulation.

[7]  F. Verheugt.  Beware of novel antiplatelet therapy in acute coronary syndrome patients with previous stroke. , 2012, Circulation.

[8]  P. Pais,et al.  Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack , 2012, Circulation.

[9]  Carin M. Van Gelder,et al.  Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. , 2012, JAMA.

[10]  G. Stone,et al.  Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. , 2012, JAMA.

[11]  Harlan M Krumholz,et al.  Hospital Strategies for Reducing Risk-Standardized Mortality Rates in Acute Myocardial Infarction , 2012, Annals of Internal Medicine.

[12]  G. Stone,et al.  Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis , 2012, The Lancet.

[13]  Sunil V. Rao,et al.  Circulation Editors' Picks: Most Read Articles on the Topic of Coronary Heart Disease , 2012 .

[14]  Kenneth R Chien,et al.  Towards regenerative therapy for cardiac disease , 2012, The Lancet.

[15]  Daniel Berman,et al.  Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.

[16]  G. Schuler,et al.  Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial , 2012, The Lancet.

[17]  J. Fox,et al.  Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2012, The American journal of cardiology.

[18]  J. Conti,et al.  Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. , 2012, Circulation.

[19]  D. Melzer.  Causes of Delay and Associated Mortality in Patients Transferred With ST-Segment-Elevation Myocardial Infarction: Miedema MD, Newell, MC, Duval S. Circulation 2011;124:1636–44. , 2012 .

[20]  A. Dans,et al.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[21]  D. Singer,et al.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[22]  Jason C. Fish,et al.  Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[23]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[24]  C. Granger,et al.  Rates of Cardiac Catheterization Cancelation for ST-Segment Elevation Myocardial Infarction After Activation by Emergency Medical Services or Emergency Physicians: Results From the North Carolina Catheterization Laboratory Activation Registry , 2012, Circulation.

[25]  Giuseppe Ambrosio,et al.  Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. , 2012, The New England journal of medicine.

[26]  Paul Burton,et al.  Rivaroxaban in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[27]  G. Dehmer,et al.  Retrospective Description and Analysis of Consecutive Catheterization Laboratory ST-Segment Elevation Myocardial Infarction Activations With Proposal, Rationale, and Use of a New Classification Scheme , 2012, Circulation. Cardiovascular quality and outcomes.

[28]  J. Alpert,et al.  gINTELLIGENCE EXPERT C ONSENSUS DOCUMENT Third Universal Definition of Myocardial Infarction , 2012 .

[29]  Charles R Bridges,et al.  Special Articles: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, Anesthesia and analgesia.

[30]  T. Henry,et al.  Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase , 2011, Circulation.

[31]  Laura Mauri,et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.

[32]  V. Chair,et al.  ACCF/AHA Practice Guideline 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011 .

[33]  G. Levine,et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Journal of the American College of Cardiology.

[34]  T. Athanasiou,et al.  Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. , 2011, European heart journal.

[35]  D. Dudek,et al.  Early glycoprotein IIb‐IIIa inhibitors in primary angioplasty‐abciximab long‐term results (EGYPT‐ALT) cooperation: individual patient’s data meta‐analysis , 2011, Journal of thrombosis and haemostasis : JTH.

[36]  John Spertus,et al.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. , 2011, Circulation.

[37]  Marcus F Stoddard,et al.  Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial , 2011, The Lancet.

[38]  G. Lamas,et al.  Long-Term Effects of Percutaneous Coronary Intervention of the Totally Occluded Infarct-Related Artery in the Subacute Phase After Myocardial Infarction , 2011, Circulation.

[39]  Doris A Taylor,et al.  Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. , 2011, JAMA.

[40]  J. Cho,et al.  Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol. , 2011, Journal of the American College of Cardiology.

[41]  T. Henry,et al.  Causes of Delay and Associated Mortality in Patients Transferred With ST-Segment–Elevation Myocardial Infarction , 2011, Circulation.

[42]  V. Pasceri,et al.  Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Inf , 2011, Journal of the American College of Cardiology.

[43]  P. Armstrong,et al.  Reperfusion Paradox in ST-Segment Elevation Myocardial Infarction , 2011, Annals of Internal Medicine.

[44]  C. Terkelsen,et al.  Health Care System Delay and Heart Failure in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Follow-up of Population-Based Medical Registry Data , 2011, Annals of Internal Medicine.

[45]  C. Terkelsen,et al.  System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial). , 2011, The American journal of cardiology.

[46]  Harlan M Krumholz,et al.  Improvements in Door-to-Balloon Time in the United States, 2005 to 2010 , 2011, Circulation.

[47]  E. Vicaut,et al.  Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial , 2011, The Lancet.

[48]  B. Gersh,et al.  Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2011, Journal of the American College of Cardiology.

[49]  D. Holmes,et al.  Clinical ResearchInterventional CardiologyCulprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction: A Pairwise and Network Meta-Analysis , 2011 .

[50]  C. Held,et al.  Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial. , 2011, Circulation.

[51]  Deepak L. Bhatt,et al.  Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting , 2011, Thrombosis and Haemostasis.

[52]  E. Antman,et al.  Use of Emergency Medical Service Transport Among Patients With ST-Segment–Elevation Myocardial Infarction: Findings From the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry–Get With the Guidelines , 2011, Circulation.

[53]  B. Klein,et al.  Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. , 2011, European heart journal.

[54]  P. Doevendans,et al.  Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. , 2011, European heart journal.

[55]  Sunil V. Rao,et al.  Bleeding avoidance strategies. Consensus and controversy. , 2011, Journal of the American College of Cardiology.

[56]  H. Krumholz,et al.  Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention. , 2011, JAMA.

[57]  F. Eberli,et al.  Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents: Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial , 2011, Circulation.

[58]  E. Antman,et al.  Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality: Insights From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel—Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38) , 2011, Circulation.

[59]  D. Faxon,et al.  Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease. , 2011, The American journal of cardiology.

[60]  C. Held,et al.  Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. , 2011, JAMA.

[61]  Sunil V. Rao,et al.  Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial , 2011, The Lancet.

[62]  C. Cannon,et al.  Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention: A Collaborative Patient-Level Meta-Analysis of 13 Randomized Studies , 2011, Circulation.

[63]  B. Gersh,et al.  Utility of left bundle branch block as a diagnostic criterion for acute myocardial infarction. , 2011, The American journal of cardiology.

[64]  K. Alexander,et al.  In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™. , 2011, The American journal of cardiology.

[65]  R. Levine,et al.  Mitral Regurgitation After Anteroapical Myocardial Infarction: New Mechanistic Insights , 2011, Circulation.

[66]  M. Mamas,et al.  Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis. , 2011, European heart journal.

[67]  C. Granger.  Who should have a routine early invasive approach after fibrinolytic therapy? , 2011, European heart journal.

[68]  Harlan M Krumholz,et al.  What Distinguishes Top-Performing Hospitals in Acute Myocardial Infarction Mortality Rates? , 2011, Annals of Internal Medicine.

[69]  Silvia G Priori,et al.  2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.

[70]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the Europe , 2011, Journal of the American College of Cardiology.

[71]  Warren J Manning,et al.  ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, , 2011, Journal of the American College of Cardiology.

[72]  S. Normand,et al.  Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty Registry. , 2011, Journal of the American College of Cardiology.

[73]  M. Zembala,et al.  Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]). , 2011, The American journal of cardiology.

[74]  N. Smedira,et al.  Effect of Timing of Chronic Preoperative Aspirin Discontinuation on Morbidity and Mortality in Coronary Artery Bypass Surgery , 2011, Circulation.

[75]  C. Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. , 2011, Journal of the American College of Cardiology.

[76]  P. Loyalka,et al.  The percutaneous ventricular assist device in severe refractory cardiogenic shock. , 2011, Journal of the American College of Cardiology.

[77]  P. Armstrong,et al.  The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: a pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST. , 2011, American heart journal.

[78]  C. Terkelsen,et al.  Urban and rural implementation of pre-hospital diagnosis and direct referral for primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction. , 2011, European heart journal.

[79]  Thomas D. Scott,et al.  Door-to-balloon times under 90 min can be routinely achieved for patients transferred for ST-segment elevation myocardial infarction percutaneous coronary intervention in a rural setting. , 2011, Journal of the American College of Cardiology.

[80]  K. Goel,et al.  Impact of Cardiac Rehabilitation on Mortality and Cardiovascular Events After Percutaneous Coronary Intervention in the Community , 2010, Circulation.

[81]  J. Rumsfeld,et al.  Door-to-balloon times for patients with ST-segment elevation myocardial infarction requiring interhospital transfer for primary percutaneous coronary intervention: a report from the national cardiovascular data registry. , 2011, American Heart Journal.

[82]  S. Greenfield,et al.  Clinical practice guidelines we can trust , 2011 .

[83]  Laura A. Levit,et al.  Finding what works in health care : standards for systematic reviews , 2011 .

[84]  Laura A. Levit,et al.  COMMITTEE ON STANDARDS FOR SYSTEMATIC REVIEWS OF COMPARATIVE EFFECTIVENESS RESEARCH , 2011 .

[85]  D. McManus,et al.  Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. , 2011, The American journal of medicine.

[86]  S. Greenfield,et al.  COMMITTEE ON STANDARDS FOR DEVELOPING TRUSTWORTHY CLINICAL PRACTICE GUIDELINES , 2011 .

[87]  H. Suryapranata,et al.  Clinical impact of simultaneous complete revascularization vs. culprit only primary angioplasty in patients with st-elevation myocardial infarction and multivessel disease: a meta-analysis , 2011, Journal of Thrombosis and Thrombolysis.

[88]  Darren K Mcguire,et al.  Glucose-lowering targets for patients with cardiovascular disease: focus on inpatient management of patients with acute coronary syndromes. , 2010, Circulation.

[89]  H. Hillege,et al.  Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration: The Comparison of Intracoronary Versus Intravenous Abciximab Administration During Emergency Reperf , 2010, Circulation.

[90]  S. Connolly,et al.  Mechanisms Underlying the Lack of Effect of Implantable Cardioverter-Defibrillator Therapy on Mortality in High-Risk Patients With Recent Myocardial Infarction: Insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT) , 2010, Circulation.

[91]  William Wijns,et al.  Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. , 2010, JACC. Cardiovascular interventions.

[92]  Gregg W Stone,et al.  Appropriate cardiac cath lab activation: optimizing electrocardiogram interpretation and clinical decision-making for acute ST-elevation myocardial infarction. , 2010, American heart journal.

[93]  T. Akasaka,et al.  Prevalence and Clinical Significance of Papillary Muscle Infarction Detected by Late Gadolinium-Enhanced Magnetic Resonance Imaging in Patients With ST-Segment Elevation Myocardial Infarction , 2010, Circulation.

[94]  C. Cannon,et al.  Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention: A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis , 2010, Circulation.

[95]  M. Gnant,et al.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010 .

[96]  R. Collins,et al.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[97]  Deepak L. Bhatt,et al.  Clopidogrel with or without omeprazole in coronary artery disease. , 2010, The New England journal of medicine.

[98]  R. Lidón,et al.  Hospital Outcome of Moderate to Severe Pericardial Effusion Complicating ST-Elevation Acute Myocardial Infarction , 2010, Circulation.

[99]  H. Gurm,et al.  Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2010, Archives of internal medicine.

[100]  H. Jneid,et al.  Arteriotomy Closure Devices for Cardiovascular Procedures: A Scientific Statement From the American Heart Association , 2010, Circulation.

[101]  Roger D. White,et al.  Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.

[102]  John E Billi,et al.  Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.

[103]  R. Neumar,et al.  Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.

[104]  K. Alexander,et al.  Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines). , 2010, JACC. Cardiovascular interventions.

[105]  Deepak L. Bhatt,et al.  Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. , 2010, The New England journal of medicine.

[106]  E. Antman,et al.  Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis , 2010, The Lancet.

[107]  F. Neumann,et al.  Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. , 2010, Journal of the American College of Cardiology.

[108]  S. Yusuf,et al.  Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial , 2010, The Lancet.

[109]  A. Camm,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.

[110]  G. Lamas,et al.  Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction. , 2010, The American journal of cardiology.

[111]  A. Moss,et al.  Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator: An Extended 8-Year Follow-Up Study of the Multicenter Automatic Defibrillator Implantation Trial II , 2010, Circulation.

[112]  J. Hartikainen,et al.  Long-Term Recording of Cardiac Arrhythmias With an Implantable Cardiac Monitor in Patients With Reduced Ejection Fraction After Acute Myocardial Infarction: The Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study , 2010, Circulation.

[113]  I. Piña,et al.  AACVPR/ACCF/AHA 2010 update: performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services: a report of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American College of Cardiology Foundation/American Heart Assoc , 2010, Circulation.

[114]  S. Yusuf,et al.  Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. , 2010, The New England journal of medicine.

[115]  Greg Mears,et al.  Impact of a Statewide ST-Segment–Elevation Myocardial Infarction Regionalization Program on Treatment Times for Women, Minorities, and the Elderly , 2010, Circulation. Cardiovascular quality and outcomes.

[116]  P. Armstrong,et al.  Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. , 2010, European heart journal.

[117]  J. Tijssen,et al.  Prediction of 1-Year Mortality With Different Measures of ST-Segment Recovery in All-Comers After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction , 2010, Circulation. Cardiovascular quality and outcomes.

[118]  Harlan M Krumholz,et al.  National Patterns of Risk-Standardized Mortality and Readmission for Acute Myocardial Infarction and Heart Failure: Update on Publicly Reported Outcomes Measures Based on the 2010 Release , 2010, Circulation. Cardiovascular quality and outcomes.

[119]  C. Terkelsen,et al.  System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. , 2010, JAMA.

[120]  B. Svennblad,et al.  Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). , 2010, Journal of the American College of Cardiology.

[121]  D. Mountain,et al.  Door‐to‐balloon times are reduced in ST‐elevation myocardial infarction by emergency physician activation of the cardiac catheterisation laboratory and immediate patient transfer , 2010, The Medical journal of Australia.

[122]  J. Messenger,et al.  Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. , 2010, Journal of the American College of Cardiology.

[123]  S. Kaul,et al.  ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association , 2010, Circulation.

[124]  F. Verheugt,et al.  Pre-hospital triage for primary angioplasty: direct referral to the intervention center versus interhospital transport. , 2010, JACC. Cardiovascular interventions.

[125]  S. Wild,et al.  Treating ST elevation myocardial infarction by primary percutaneous coronary intervention, in-hospital thrombolysis and prehospital thrombolysis. An observational study of timelines and outcomes in 625 patients , 2010, Emergency Medicine Journal.

[126]  C. White,et al.  Doing what's right for the resuscitated , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[127]  P. Armstrong,et al.  Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. , 2010, European heart journal.

[128]  H. Krumholz,et al.  Trends in race-based differences in door-to-balloon times. , 2010, Archives of internal medicine.

[129]  S. Pocock,et al.  A risk score to predict bleeding in patients with acute coronary syndromes. , 2010, Journal of the American College of Cardiology.

[130]  Alan S. Go,et al.  Population trends in the incidence and outcomes of acute myocardial infarction. , 2010, The New England journal of medicine.

[131]  J. Brophy,et al.  Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. , 2010, JAMA.

[132]  John A Spertus,et al.  Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. , 2010, JAMA.

[133]  J. Dery,et al.  Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study. , 2010, The American journal of cardiology.

[134]  P. Stella,et al.  Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. , 2010, Journal of the American College of Cardiology.

[135]  K. Eagle,et al.  Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. , 2010, European heart journal.

[136]  S. Bangalore,et al.  A routine invasive strategy for out-of-hospital cardiac arrest survivors: are we there yet? , 2010, Circulation. Cardiovascular interventions.

[137]  K. Eagle,et al.  Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events. , 2010, European heart journal.

[138]  P. Kirchhof,et al.  Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) a , 2010, European heart journal.

[139]  A. Terzic,et al.  Regenerative medicine advancing health care 2020. , 2010, Journal of the American College of Cardiology.

[140]  Liuquan Cheng,et al.  A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. , 2010, Journal of the American College of Cardiology.

[141]  K. Alexander,et al.  Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative. , 2010, American Heart Journal.

[142]  R. Eisenstein,et al.  An evaluation of the accuracy of emergency physician activation of the cardiac catheterization laboratory for patients with suspected ST-segment elevation myocardial infarction. , 2010, Annals of emergency medicine.

[143]  E. Bonnefoy,et al.  Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study. , 2010, Archives of cardiovascular diseases.

[144]  Denise H. Daudelin,et al.  Improving Use of Prehospital 12-Lead ECG for Early Identification and Treatment of Acute Coronary Syndrome and ST-Elevation Myocardial Infarction , 2010, Circulation. Cardiovascular quality and outcomes.

[145]  E. Antman,et al.  Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial. , 2010, European heart journal.

[146]  R. Virmani,et al.  Microvascular obstruction: underlying pathophysiology and clinical diagnosis. , 2010, Journal of the American College of Cardiology.

[147]  Daniel Davis,et al.  Survival after application of automatic external defibrillators before arrival of the emergency medical system: evaluation in the resuscitation outcomes consortium population of 21 million. , 2010, Journal of the American College of Cardiology.

[148]  K. Alexander,et al.  Medication Errors in Acute Cardiovascular and Stroke Patients: A Scientific Statement From the American Heart Association , 2010, Circulation.

[149]  Matthew K Wynia,et al.  Collection of data on patients' race and ethnic group by physician practices. , 2010, The New England journal of medicine.

[150]  J. Vincent,et al.  Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.

[151]  Carin M. Van Gelder,et al.  Early Cardiac Catheterization Laboratory Activation by Paramedics for Patients with ST-segment Elevation Myocardial Infarction on Prehospital 12-Lead Electrocardiograms , 2010, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[152]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[153]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[154]  R. Neumar,et al.  Regional systems of care for out-of-hospital cardiac arrest: A policy statement from the American Heart Association. , 2010, Circulation.

[155]  S. Halvorsen,et al.  Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). , 2010, Journal of the American College of Cardiology.

[156]  U. Elkayam,et al.  Venous Thromboembolism in Hospitalized Patients With Heart Failure: Incidence, Prognosis, and Prevention , 2010, Circulation. Heart failure.

[157]  K. Kern,et al.  Emergent percutaneous coronary intervention for resuscitated victims of out‐of‐hospital cardiac arrest , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[158]  Samin K. Sharma,et al.  Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. , 2010, JACC. Cardiovascular interventions.

[159]  Roger D. White,et al.  Using prehospital electrocardiograms to improve door-to-balloon time for transferred patients with ST-elevation myocardial infarction: a case of extreme performance. , 2010, Circulation. Cardiovascular quality and outcomes.

[160]  Ingrid M. Nembhard,et al.  National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance. , 2009, Journal of the American College of Cardiology.

[161]  L. Køber,et al.  Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data , 2009, The Lancet.

[162]  B. Gersh,et al.  Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. , 2009, The New England journal of medicine.

[163]  J. Ferrières,et al.  Genetic determinants of response to clopidogrel and cardiovascular events. , 2009, The New England journal of medicine.

[164]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[165]  L. Morrison,et al.  Routine early angioplasty after fibrinolysis for acute myocardial infarction. , 2009, The New England journal of medicine.

[166]  A. Habets,et al.  Defibrillator implantation early after myocardial infarction. , 2009, The New England journal of medicine.

[167]  David Dai,et al.  Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. , 2009, JAMA.

[168]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[169]  R. Califf,et al.  Early versus delayed, provisional eptifibatide in acute coronary syndromes. , 2009, The New England journal of medicine.

[170]  S. Yusuf,et al.  Early versus delayed invasive intervention in acute coronary syndromes. , 2009, The New England journal of medicine.

[171]  J. Ornato,et al.  2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[172]  B. Gersh,et al.  Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The “Dark Side” of Reperfusion , 2009, Circulation.

[173]  D. Dudek,et al.  Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors. , 2009, Atherosclerosis.

[174]  G. Filippatos,et al.  Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial † , 2009, European journal of heart failure.

[175]  M. A. Soliman Hamad,et al.  Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[176]  C. Cannon,et al.  Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly: Findings From the Get With the Guidelines Quality-Improvement Program , 2009, Circulation. Cardiovascular quality and outcomes.

[177]  B. King.  Chain of Survival , 2009 .

[178]  G. Stone,et al.  Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2009, Journal of the American College of Cardiology.

[179]  E. Topol,et al.  1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial. , 2009, JACC. Cardiovascular interventions.

[180]  E. Antman,et al.  Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials , 2009, The Lancet.

[181]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[182]  J. Ottervanger,et al.  Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction , 2009, Coronary artery disease.

[183]  M. Desai,et al.  Statistical Models and Patient Predictors of Readmission for Acute Myocardial Infarction: A Systematic Review , 2009, Circulation. Cardiovascular quality and outcomes.

[184]  M. Bell,et al.  Sustaining Improvement in Door-to-Balloon Time Over 4 Years: The Mayo Clinic ST-Elevation Myocardial Infarction Protocol , 2009, Circulation. Cardiovascular quality and outcomes.

[185]  A. Kaltoft,et al.  Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. , 2009, European heart journal.

[186]  E. Antman,et al.  Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON‐TIMI 38 , 2009, Journal of clinical pharmacology.

[187]  P. Armstrong,et al.  Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. , 2009, European heart journal.

[188]  F. Burzotta,et al.  Myocardial no-reflow in humans. , 2009, Journal of the American College of Cardiology.

[189]  V. Bezlyak,et al.  Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[190]  S. Normand,et al.  Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission , 2009, Circulation. Cardiovascular quality and outcomes.

[191]  Héctor Bueno,et al.  Mejora del pronóstico tras parada cardiorrespiratoria de causa cardiaca mediante el empleo de hipotermia moderada: comparación con un grupo control , 2009 .

[192]  H. Gurm,et al.  The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. , 2009, JACC. Cardiovascular interventions.

[193]  P. Touboul,et al.  Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. , 2009, European heart journal.

[194]  E. Antman,et al.  Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial. , 2009, European heart journal.

[195]  S. Normand,et al.  Cardiac rehabilitation and survival in older coronary patients. , 2009, Journal of the American College of Cardiology.

[196]  D. Berman,et al.  ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Associa , 2009, Journal of the American College of Cardiology.

[197]  Y. Adler,et al.  Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention. , 2009, The American journal of cardiology.

[198]  Sunil V. Rao,et al.  Bleeding in Patients Undergoing Percutaneous Coronary Intervention: The Development of a Clinical Risk Algorithm From the National Cardiovascular Data Registry , 2009, Circulation. Cardiovascular interventions.

[199]  S. Castrejon,et al.  Improved prognosis after using mild hypothermia to treat cardiorespiratory arrest due to a cardiac cause: comparison with a control group. , 2009, Revista espanola de cardiologia.

[200]  Richard Hellman,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[201]  H. Anderson,et al.  Acute coronary syndromes: don't bypass the clopidogrel. , 2009, Journal of the American College of Cardiology.

[202]  J. Ware,et al.  Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. , 2009, Journal of the American College of Cardiology.

[203]  Harlan M Krumholz,et al.  Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study , 2009, BMJ : British Medical Journal.

[204]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[205]  Harlan M Krumholz,et al.  Research in action: using positive deviance to improve quality of health care , 2009, Implementation science : IS.

[206]  P. Armstrong,et al.  Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. , 2009, JAMA.

[207]  G. De Luca,et al.  Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis. , 2009, Journal of the American College of Cardiology.

[208]  C. Callaway,et al.  Review of A Large Clinical Series: Coronary Angiography Predicts Improved Outcome Following Cardiac Arrest: Propensity-adjusted Analysis , 2009, Journal of intensive care medicine.

[209]  S. Saba,et al.  Location of Acute Myocardial Infarction and Associated Arrhythmias and Outcome , 2009, Clinical cardiology.

[210]  P. Teirstein,et al.  Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial. , 2009, American heart journal.

[211]  C. Albert,et al.  Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women , 2009, Circulation.

[212]  J. Denollet,et al.  The Association of Cognitive and Somatic Depressive Symptoms With Depression Recognition and Outcomes After Myocardial Infarction , 2009, Circulation. Cardiovascular quality and outcomes.

[213]  G. Paolisso,et al.  Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. , 2009, Journal of the American College of Cardiology.

[214]  H. Gurm,et al.  A Comparison of Abciximab and Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Primary Percutaneous Coronary Intervention: A Meta-Analysis of Contemporary Randomized Controlled Trials , 2009, Circulation. Cardiovascular interventions.

[215]  H. Krumholz,et al.  Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. , 2009, JAMA.

[216]  S. Nekolla,et al.  Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial , 2009, Circulation.

[217]  Sunil V. Rao,et al.  Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score , 2009, Circulation.

[218]  G. Stone,et al.  Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. , 2009, International journal of cardiology.

[219]  Mark V. Williams,et al.  Transitions of Care Consensus Policy Statement American College of Physicians-Society of General Internal Medicine-Society of Hospital Medicine-American Geriatrics Society-American College of Emergency Physicians-Society of Academic Emergency Medicine , 2009, Journal of General Internal Medicine.

[220]  E. Antman,et al.  Cytochrome p-450 polymorphisms and response to clopidogrel. , 2009, The New England journal of medicine.

[221]  B. McNally,et al.  Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on Door-to-Balloon times across 10 independent regions. , 2009, JACC. Cardiovascular interventions.

[222]  K. Anstrom,et al.  Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. , 2009, American Heart Journal.

[223]  P. Gurbel,et al.  The drug–drug interaction between proton pump inhibitors and clopidogrel , 2009, Canadian Medical Association Journal.

[224]  Peter C. Austin,et al.  A population-based study of the drug interaction between proton pump inhibitors and clopidogrel , 2009, Canadian Medical Association Journal.

[225]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[226]  Deepak L. Bhatt,et al.  Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding , 2009, Annals of Internal Medicine.

[227]  B. Giusti,et al.  Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis. , 2009, The American journal of cardiology.

[228]  M. Hadamitzky,et al.  Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel , 2009, Thrombosis and Haemostasis.

[229]  P. Armstrong,et al.  Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction. , 2009, Circulation.

[230]  P Michael Ho,et al.  Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. , 2009, JAMA.

[231]  J. Gore,et al.  Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]). , 2009, The American journal of cardiology.

[232]  H. Thiele,et al.  Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial , 2009, American heart journal.

[233]  S. de Servi,et al.  Emergency percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: early and medium-term outcome. , 2009, American heart journal.

[234]  E. Antman,et al.  Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial , 2009, The Lancet.

[235]  Katherine C. Wu.  Fighting the "fire" of myocardial reperfusion injury: how to define success? , 2009, Journal of the American College of Cardiology.

[236]  E. W. Hancock,et al.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Card , 2009, Circulation.

[237]  P. Doevendans,et al.  Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. , 2009, Journal of the American College of Cardiology.

[238]  Stephen A. Martin,et al.  A Reengineered Hospital Discharge Program to Decrease Rehospitalization , 2009, Annals of Internal Medicine.

[239]  Vinay R. Hosmane,et al.  Survival and neurologic recovery in patients with ST-segment elevation myocardial infarction resuscitated from cardiac arrest. , 2009, Journal of the American College of Cardiology.

[240]  H. Krumholz,et al.  The door-to-balloon alliance for quality: who joins national collaborative efforts and why? , 2009, Joint Commission journal on quality and patient safety.

[241]  F. Fedele,et al.  Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. , 2009, Journal of the American College of Cardiology.

[242]  G. Montalescot,et al.  Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study , 2009, The Lancet.

[243]  J. Panza,et al.  Outcomes and quality of life in patients>or=85 years of age with ST-elevation myocardial infarction. , 2009, The American journal of cardiology.

[244]  C. Cannon,et al.  Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry. , 2009, Journal of the American College of Cardiology.

[245]  D. Cone,et al.  Can Paramedics Read ST-segment Elevation Myocardial Infarction on Prehospital 12-Lead Electrocardiograms? , 2009, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[246]  J. Tijssen,et al.  A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? , 2008, European heart journal.

[247]  A. Kastrati,et al.  Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention. , 2008, European heart journal.

[248]  S. Yusuf,et al.  Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study. , 2008, European heart journal.

[249]  A. Denktas,et al.  Drug-eluting stents for acute myocardial infarction. , 2007, Expert opinion on pharmacotherapy.

[250]  G. Moneta.  Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction , 2009 .

[251]  B. Gersh.  Facilitated PCI in Patients with ST-Elevation Myocardial Infarction , 2009 .

[252]  A. Budaj,et al.  Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). , 2009, JACC. Cardiovascular interventions.

[253]  W. Bautz,et al.  Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. , 2009, Radiology.

[254]  Elizabeth DeLong,et al.  ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. , 2008, Journal of the American College of Cardiology.

[255]  J. Dery,et al.  Nonrandomized Comparison of Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention for the Treatment of Unprotected Left Main Coronary Artery Disease in Octogenarians , 2008, Circulation.

[256]  A. Maresta,et al.  Single or multivessel percutaneous coronary intervention in ST‐elevation myocardial infarction patients , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[257]  Deepak L. Bhatt,et al.  Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. , 2008, European heart journal.

[258]  Michael Weis,et al.  Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. , 2008, European heart journal.

[259]  S. Normand,et al.  Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes Mellitus: Results From the Massachusetts Data Analysis Center Registry , 2008, Circulation.

[260]  R. D. de Winter,et al.  A new ECG sign of proximal LAD occlusion. , 2008, The New England journal of medicine.

[261]  D. Mark,et al.  Clopidogrel use and bleeding after coronary artery bypass graft surgery. , 2008, American heart journal.

[262]  J. Jensen,et al.  The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary , 2008, Current cardiology reviews.

[263]  S. Steinhubl,et al.  Abstract 3999: Baseline Proton Pump Inhibitor Use is Associated with Increased Cardiovascular Events With and Without the Use of Clopidogrel in the CREDO Trial , 2008 .

[264]  R. Epstein,et al.  Abstract 3998: Proton Pump Inhibitors Effect on Clopidogrel Effectiveness: The Clopidogrel Medco Outcomes Study , 2008 .

[265]  Viola Vaccarino,et al.  Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. , 2008, Archives of internal medicine.

[266]  E. Wijdicks,et al.  Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. , 2008, Archives of neurology.

[267]  E. Antman.  Time is muscle: translation into practice. , 2008, Journal of the American College of Cardiology.

[268]  W. Laskey,et al.  Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. , 2008, American heart journal.

[269]  J Thomas Bigger,et al.  Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip , 2008, Circulation.

[270]  C. Callaway,et al.  Regional variation in out-of-hospital cardiac arrest incidence and outcome. , 2008, JAMA.

[271]  Vivian Gu,et al.  Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. , 2008, The New England journal of medicine.

[272]  R. Giugliano,et al.  Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis. , 2008, Journal of the American College of Cardiology.

[273]  Á. Avezum,et al.  Impact of In-Hospital Revascularization on Survival in Patients With Non–ST-Elevation Acute Coronary Syndrome and Congestive Heart Failure , 2008, Circulation.

[274]  Harlan M Krumholz,et al.  Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursi , 2008, Circulation.

[275]  Renda Soylemez Wiener,et al.  Ill Adults: A Meta-analysis Benefits and Risks of Tight Glucose Control in Critically , 2010 .

[276]  J. Ottervanger,et al.  Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial , 2008, The Lancet.

[277]  A. Shah,et al.  A comparison of door-to-balloon times and false-positive activations between emergency department and out-of-hospital activation of the coronary catheterization team. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[278]  Fang-Shu Ou,et al.  Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. , 2008, JACC. Cardiovascular interventions.

[279]  B. Nallamothu,et al.  Commentary: the role of percutaneous coronary intervention in ST-segment-elevation myocardial infarction. , 2008, Circulation.

[280]  H. White.  Systems of care: need for hub-and-spoke systems for both primary and systematic percutaneous coronary intervention after fibrinolysis. , 2008, Circulation.

[281]  W. Markiewicz,et al.  Impact of red blood cell transfusion on clinical outcomes in patients with acute myocardial infarction. , 2008, The American journal of cardiology.

[282]  J. Ferrières,et al.  Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for , 2022 .

[283]  Deepak L. Bhatt,et al.  The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. , 2008, American heart journal.

[284]  E. V. van Beek,et al.  The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. , 2008, AJR. American journal of roentgenology.

[285]  L. Perrault,et al.  Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[286]  P. Raskin,et al.  Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2008, Anesthesiology.

[287]  H. Krumholz,et al.  Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry. , 2008, Journal of the American College of Cardiology.

[288]  F. Zijlstra,et al.  Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study , 2008, The Lancet.

[289]  R. Beyth,et al.  Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[290]  P. Shah,et al.  Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis. , 2008, JACC. Cardiovascular interventions.

[291]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[292]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[293]  B. Gersh,et al.  Bivalirudin during primary PCI in acute myocardial infarction. , 2008, The New England journal of medicine.

[294]  S. Mayer,et al.  Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. , 2008, The New England journal of medicine.

[295]  G. Biondi-Zoccai,et al.  Late percutaneous coronary intervention for the totally occluded infarct‐related artery: A meta‐analysis of the effects on cardiac function and remodeling , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[296]  Young-Hak Kim,et al.  Stents versus coronary-artery bypass grafting for left main coronary artery disease. , 2008, The New England journal of medicine.

[297]  F. Prati,et al.  Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. , 2008, JAMA.

[298]  S. Stevens,et al.  Rescue angioplasty for failed thrombolysis in older patients: insights from the REACT trial. , 2008, International journal of cardiology.

[299]  P. Barragan,et al.  Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study. , 2008, Journal of the American College of Cardiology.

[300]  A. Jacobs,et al.  Primary percutaneous coronary intervention without cardiac surgery on-site: coming to a hospital near you? , 2008, American heart journal.

[301]  K. Winters,et al.  Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel , 2008, Journal of clinical pharmacology.

[302]  Samin K. Sharma,et al.  Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction. , 2008, JACC. Cardiovascular interventions.

[303]  M. Bell,et al.  Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. , 2008, JACC. Cardiovascular interventions.

[304]  T. Mihaljevic,et al.  Duration of red-cell storage and complications after cardiac surgery. , 2008, The New England journal of medicine.

[305]  G. Stone,et al.  Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. , 2008, The American journal of cardiology.

[306]  J D Hilton,et al.  Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) , 2008, Heart.

[307]  J. Brinker.  The left main facts: faced, spun, but alas too few. , 2008, Journal of the American College of Cardiology.

[308]  S. Yusuf,et al.  Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. , 2008, Journal of the American College of Cardiology.

[309]  A. G. Gittenberger-de Groot,et al.  Deciphering the endothelial shear stress sensor. , 2008, Circulation.

[310]  H. Thomsen,et al.  The ACTIVE Trial: Comparison of the Effects on Renal Function of Iomeprol-400 and Iodixanol-320 in Patients With Chronic Kidney Disease Undergoing Abdominal Computed Tomography , 2008, Investigative radiology.

[311]  H. Krumholz,et al.  Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk , 2008, Circulation.

[312]  M. Flather,et al.  Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial , 2008, The Lancet.

[313]  P Michael Ho,et al.  Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. , 2008, JAMA.

[314]  D. Dudek,et al.  Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. , 2008, Journal of the American College of Cardiology.

[315]  Salim Yusuf,et al.  The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial. , 2008, European heart journal.

[316]  J. Soar,et al.  Post resuscitation care--time for a care bundle? , 2008, Resuscitation.

[317]  R. Kornowski,et al.  Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus. , 2008, American heart journal.

[318]  H. Krumholz,et al.  A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality. , 2008, JACC. Cardiovascular interventions.

[319]  G. Biondi-Zoccai,et al.  Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty. , 2008, Journal of interventional cardiology.

[320]  Y. Hasin,et al.  Culprit only versus complete coronary revascularization during primary PCI. , 2008, International journal of cardiology.

[321]  Dominique Mottier,et al.  Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. , 2008, Journal of the American College of Cardiology.

[322]  J. Trickett,et al.  A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. , 2008, The New England journal of medicine.

[323]  Christopher E. Buller,et al.  2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2008, Circulation.

[324]  S. Ellis,et al.  Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. , 2008, The American journal of cardiology.

[325]  Christopher E. Buller,et al.  2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2008, Journal of the American College of Cardiology.

[326]  J. Dery,et al.  Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[327]  William Wijns,et al.  [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[328]  Harlan M. Krumholz,et al.  ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Eleva , 2006, Journal of the American College of Cardiology.

[329]  B. Gersh.  A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications , 2008 .

[330]  K. Isaaz,et al.  Echocardiographic assessment of the incidence of mechanical complications during the early phase of myocardial infarction in the reperfusion era: a French multicentre prospective registry. , 2008, Archives of cardiovascular diseases.

[331]  B. Uretsky,et al.  Thrombus aspiration during primary percutaneous coronary intervention. , 2008, The New England journal of medicine.

[332]  Sanjay Kaul,et al.  ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. , 2008, Journal of the American College of Cardiology.

[333]  E. Antman,et al.  Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis , 2008, Journal of Thrombosis and Thrombolysis.

[334]  Barbara T. Unger,et al.  "False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction. , 2007, JAMA.

[335]  E. Antman,et al.  Prasugrel Compared With High Loading– and Maintenance–Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial , 2007, Circulation.

[336]  J. Gore,et al.  Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction? , 2007, Circulation.

[337]  J. Ioannidis,et al.  Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients. , 2007, American heart journal.

[338]  K. Anstrom,et al.  Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. , 2007, JAMA.

[339]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[340]  Marco Valgimigli,et al.  Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. , 2007, European heart journal.

[341]  P. Aegerter,et al.  Efficacy of therapeutic hypothermia after out-of-hospital cardiac arrest due to ventricular fibrillation. , 2007, Resuscitation.

[342]  H. Krumholz,et al.  Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction. , 2007, The American journal of cardiology.

[343]  Sharon-Lise T Normand,et al.  Use of Cardiac Rehabilitation by Medicare Beneficiaries After Myocardial Infarction or Coronary Bypass Surgery , 2007, Circulation.

[344]  A. Íñiguez,et al.  Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. , 2007, The American journal of cardiology.

[345]  G. Schuler,et al.  Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. , 2007, European heart journal.

[346]  A. Jacobs,et al.  Regional systems of care for patients with ST-elevation myocardial infarction: being at the right place at the right time. , 2007, Circulation.

[347]  B. Gersh,et al.  Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for ST-Elevation Myocardial Infarction: The Mayo Clinic STEMI Protocol , 2007, Circulation.

[348]  Timothy D. Henry,et al.  A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction , 2007, Circulation.

[349]  J. Ornato,et al.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie , 2007, Journal of the American College of Cardiology.

[350]  S. Pocock,et al.  Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. , 2007, European heart journal.

[351]  R. Gibbons,et al.  Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). , 2007, The American journal of cardiology.

[352]  E. Antman,et al.  Development of Systems of Care for ST-Elevation Myocardial Infarction Patients , 2007 .

[353]  J. Matějka,et al.  Out-of-Hospital Cardiac Arrests in Patients with Acute ST Elevation Myocardial Infarctions in the East Bohemian Region over the Period 2002–2004 , 2007, Cardiology.

[354]  P. Serruys,et al.  Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery: A Multicenter Registry , 2007, Circulation.

[355]  M. Worthley,et al.  Prognostic implication of hyperglycemia in myocardial infarction and primary angioplasty. , 2007, The American journal of medicine.

[356]  Y. Choi,et al.  Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery. , 2007, The Journal of thoracic and cardiovascular surgery.

[357]  Samin K. Sharma,et al.  Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.

[358]  M. Ishihara,et al.  Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. , 2007, The American journal of cardiology.

[359]  B. Lewis,et al.  Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. , 2007, Journal of the American College of Cardiology.

[360]  E. Antman,et al.  The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. , 2007, Journal of the American College of Cardiology.

[361]  M. Holzer,et al.  Thrombolytic therapy vs primary percutaneous intervention after ventricular fibrillation cardiac arrest due to acute ST-segment elevation myocardial infarction and its effect on outcome. , 2007, The American journal of emergency medicine.

[362]  Vera Bittner,et al.  Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Pr , 2007, Circulation.

[363]  Deepak L. Bhatt,et al.  Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. , 2007, Journal of the American College of Cardiology.

[364]  M. Naylor,et al.  Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. , 2007, Circulation.

[365]  A. Schoenenberger,et al.  Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. , 2007, JAMA.

[366]  K. Eagle,et al.  Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. , 2007, JAMA.

[367]  V. Pasceri,et al.  Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. , 2007, American heart journal.

[368]  Timothy J Gardner,et al.  Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Circulation.

[369]  M. Leoncini,et al.  Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial). , 2007, Journal of the American College of Cardiology.

[370]  J. Herlitz,et al.  Treatment and outcome in post-resuscitation care after out-of-hospital cardiac arrest when a modern therapeutic approach was introduced. , 2007, Resuscitation.

[371]  Doron Aronson,et al.  Primary percutaneous coronary intervention after out-of-hospital cardiac arrest: patients and outcomes. , 2007, The Israel Medical Association journal : IMAJ.

[372]  P. Steen,et al.  Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest. , 2007, Resuscitation.

[373]  H. White,et al.  Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. , 2007, Journal of the American College of Cardiology.

[374]  P. Lesault,et al.  Six-Month Outcome of Emergency Percutaneous Coronary Intervention in Resuscitated Patients After Cardiac Arrest Complicating ST-Elevation Myocardial Infarction , 2007, Circulation.

[375]  H. Krumholz,et al.  Financial barriers to health care and outcomes after acute myocardial infarction. , 2007, JAMA.

[376]  M. Noc,et al.  Acute ST-elevation myocardial infarction after successful cardiopulmonary resuscitation. , 2007, Resuscitation.

[377]  J. Ioannidis,et al.  Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. , 2007, The American journal of cardiology.

[378]  J. Ware,et al.  Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. , 2007, JAMA.

[379]  C. Grines,et al.  Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Journal of the American College of Cardiology.

[380]  J. E. Sousa,et al.  Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial. , 2007, American heart journal.

[381]  S. Normand,et al.  Socioeconomic disparities in outcomes after acute myocardial infarction. , 2007, American heart journal.

[382]  R. Califf,et al.  The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction. , 2007, European heart journal.

[383]  J. Tu,et al.  Clinical ResearchInterventional CardiologyRescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta-Analysis of Randomized Trials , 2007 .

[384]  Fernando Costa,et al.  Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus , 2007, Diabetes Care.

[385]  G. Lamas,et al.  Focused Update of the ACC / AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2007 .

[386]  G. Richardt,et al.  Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction , 2007, Clinical Research in Cardiology.

[387]  Patrick Hunziker,et al.  Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. , 2006, Journal of the American College of Cardiology.

[388]  G. Lamas,et al.  Coronary intervention for persistent occlusion after myocardial infarction. , 2006, The New England journal of medicine.

[389]  R. Shaw,et al.  Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug‐eluting stent era—a report from the American College of Cardiology‐National Cardiovascular data registry (ACC‐NCDR) , 2006 .

[390]  P. Armstrong,et al.  Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center. , 2006, American heart journal.

[391]  David P Miller,et al.  Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy , 2006, Circulation.

[392]  C. Granger,et al.  Reperfusion of acute myocardial infarction in North Carolina emergency departments (RACE): study design. , 2006, American heart journal.

[393]  P. McGettigan,et al.  Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. , 2006, JAMA.

[394]  G. Montalescot,et al.  Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. , 2006, Journal of the American College of Cardiology.

[395]  C. Granger,et al.  Rationale for establishing regional ST-elevation myocardial infarction receiving center (SRC) networks. , 2006, American heart journal.

[396]  E. Antman,et al.  Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). , 2006, American heart journal.

[397]  G. Filippatos,et al.  The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. , 2006, European heart journal.

[398]  Sung-joon Min,et al.  The care transitions intervention: results of a randomized controlled trial. , 2006, Archives of internal medicine.

[399]  A. Zeiher,et al.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[400]  Young‐Bae Park,et al.  Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. , 2006, Journal of the American College of Cardiology.

[401]  S. Yusuf,et al.  Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes , 2006, Circulation.

[402]  J. Brinker,et al.  A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. , 2006, Journal of the American College of Cardiology.

[403]  Christopher P Cannon,et al.  Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. , 2006, Journal of the American College of Cardiology.

[404]  Seung‐Jung Park,et al.  Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. , 2006, The American journal of cardiology.

[405]  D. Berman,et al.  Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. , 2006, Journal of the American College of Cardiology.

[406]  A. Branzi,et al.  Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). , 2006, The American journal of cardiology.

[407]  P. Armstrong.  A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. , 2006, European heart journal.

[408]  K. Eagle,et al.  The 12-lead electrocardiogram as a predictive tool of mortality after acute myocardial infarction: current status in an era of revascularization and reperfusion. , 2006, American heart journal.

[409]  L. Køber,et al.  Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction , 2006, Circulation.

[410]  R. Eckel,et al.  Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. , 2006, Circulation.

[411]  Harlan M. Krumholz,et al.  Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement: Results From the PREMIER Registry , 2006, Circulation.

[412]  H. White,et al.  Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. , 2006, JAMA.

[413]  C. Macaya,et al.  Percutaneous coronary intervention for cardiac arrest secondary to ST-elevation acute myocardial infarction. Influence of immediate paramedical/medical assistance on clinical outcome. , 2006, The Journal of invasive cardiology.

[414]  Harlan M Krumholz,et al.  Door-to-drug and door-to-balloon times: where can we improve? Time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI). , 2006, American heart journal.

[415]  J. Emberson,et al.  Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials , 2006, BMJ : British Medical Journal.

[416]  D. Faxon,et al.  Left main coronary revascularization at the crossroads. , 2006, Circulation.

[417]  O. Alfieri,et al.  Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis: A Single-Center Experience , 2006, Circulation.

[418]  G. Maurer,et al.  Implementation of Guidelines Improves the Standard of Care: The Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI Registry) , 2006, Circulation.

[419]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[420]  Peter Moyer,et al.  Recommendation to Develop Strategies to Increase the Number of ST-Segment–Elevation Myocardial Infarction Patients With Timely Access to Primary Percutaneous Coronary Intervention , 2006, Circulation.

[421]  L. Wallentin,et al.  Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. , 2006, European heart journal.

[422]  E. Antman,et al.  Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. , 2006, The New England journal of medicine.

[423]  S. Yusuf,et al.  Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. , 2006, JAMA.

[424]  Irene Katzan,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Stroke.

[425]  S. Ghiringhelli,et al.  Performing versus deferring coronary angioplasty based on functional evaluation of vessel stenosis by pressure measurements: a clinical outcome study , 2006, Journal of cardiovascular medicine.

[426]  G. Biondi-Zoccai,et al.  Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients. , 2006, European heart journal.

[427]  Harlan M. Krumholz,et al.  Achieving Rapid Door-To-Balloon Times: How Top Hospitals Improve Complex Clinical Systems , 2006, Circulation.

[428]  D. Baim,et al.  Drug-eluting stenting for unprotected left main coronary artery disease: are we ready to replace bypass surgery? , 2006, Journal of the American College of Cardiology.

[429]  Robert M Califf,et al.  A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. , 2006, Journal of the American College of Cardiology.

[430]  P. Shah,et al.  Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. , 2006, Journal of the American College of Cardiology.

[431]  J. Boura,et al.  Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials , 2006, The Lancet.

[432]  P. Armstrong,et al.  Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial , 2006, The Lancet.

[433]  R. Califf,et al.  Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction. , 2006, American heart journal.

[434]  S. Dymarkowski,et al.  Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial , 2006, The Lancet.

[435]  J. Ornato,et al.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). , 2006, Circulation.

[436]  H. Krumholz,et al.  Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. , 2006, Journal of the American College of Cardiology.

[437]  P. Chou,et al.  Reciprocal changes in 12-lead electrocardiography can predict left main coronary artery lesion in patients with acute myocardial infarction. , 2006, International heart journal.

[438]  Joseph P Ornato,et al.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). , 2006, Journal of the American College of Cardiology.

[439]  S. Stevens,et al.  Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. , 2005, The New England journal of medicine.

[440]  K. Alexander,et al.  Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. , 2005, JAMA.

[441]  E. Romagnoli,et al.  Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI. , 2005, International journal of cardiology.

[442]  R. Collins,et al.  Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[443]  R. Collins,et al.  Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[444]  R. Califf,et al.  Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. , 2005, The American journal of cardiology.

[445]  Ming-Chin Yeh,et al.  Public health strategies for preventing and controlling overweight and obesity in school and worksite settings: a report on recommendations of the Task Force on Community Preventive Services. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[446]  R. Califf,et al.  Renal function, concomitant medication use and outcomes following acute coronary syndromes. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[447]  G. Schuler,et al.  Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. , 2005, European heart journal.

[448]  Lucila Ohno-Machado,et al.  Discrimination and calibration of mortality risk prediction models in interventional cardiology , 2005, J. Biomed. Informatics.

[449]  L. Køber,et al.  Simple Risk Stratification at Admission to Identify Patients With Reduced Mortality From Primary Angioplasty , 2005, Circulation.

[450]  A. Michelson.  Platelet function testing in cardiovascular diseases , 2005, Hematology.

[451]  William Wijns,et al.  Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. , 2005, Journal of the American College of Cardiology.

[452]  G. Wells,et al.  Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). , 2005, Journal of the American College of Cardiology.

[453]  W. Markiewicz,et al.  Late thrombosis of sirolimus‐eluting stents following noncardiac surgery , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[454]  J. Hochman,et al.  Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. , 2005, JAMA.

[455]  R. Giugliano,et al.  U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. , 2005, Journal of the American College of Cardiology.

[456]  Darren K Mcguire,et al.  Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. , 2005, European heart journal.

[457]  S. Nekolla,et al.  Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial , 2005 .

[458]  J. Ottervanger,et al.  Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus. , 2005, The American journal of cardiology.

[459]  W. Gibler,et al.  Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. , 2005, American heart journal.

[460]  F. Neumann,et al.  Time Dependence of Platelet Inhibition After a 600-mg Loading Dose of Clopidogrel in a Large, Unselected Cohort of Candidates for Percutaneous Coronary Intervention , 2005, Circulation.

[461]  Deepak L. Bhatt,et al.  Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. , 2005, The American journal of cardiology.

[462]  P. Touboul,et al.  Significance of serum troponin I elevation in patients with acute aortic dissection of the ascending aorta , 2005, Acta cardiologica.

[463]  A. Skene,et al.  Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. , 2005, The New England journal of medicine.

[464]  A. Maggioni,et al.  VALIANT (VALsartan In Acute myocardial iNfarcTion) trial , 2005, Expert opinion on pharmacotherapy.

[465]  E. Coleman,et al.  Assessing the Quality of Preparation for Posthospital Care from the Patient's Perspective: The Care Transitions Measure , 2005, Medical care.

[466]  H. Kestler,et al.  Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. , 2005, European heart journal.

[467]  L. Demers,et al.  Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization. , 2005, American journal of physiology. Heart and circulatory physiology.

[468]  I. Iakovou,et al.  Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main , 2005, Circulation.

[469]  L. Shaw,et al.  Thrombolysis and Counterpulsation to Improve Survival in Myocardial Infarction Complicated by Hypotension and Suspected Cardiogenic Shock or Heart Failure: Results of the TACTICS Trial , 2005, Journal of Thrombosis and Thrombolysis.

[470]  K. Anstrom,et al.  Identification, Diagnosis and Treatment of Heparin-induced Thrombocytopenia and Thrombosis: A Registry of Prolonged Heparin Use and Thrombocytopenia among Hospitalized Patients with and without Cardiovascular Disease , 2005, Journal of Thrombosis and Thrombolysis.

[471]  Jun Zhu,et al.  Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. , 2005, JAMA.

[472]  M. Lauer,et al.  Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Su , 2005, Circulation.

[473]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[474]  K. Kario,et al.  Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome. , 2005, Thrombosis research.

[475]  Eric Fain,et al.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.

[476]  R. Porcher,et al.  DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. , 2004, European heart journal.

[477]  M. Pfeffer,et al.  Angiotensin-converting-enzyme inhibition in stable coronary artery disease. , 2004, The New England journal of medicine.

[478]  Sunil V. Rao,et al.  Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[479]  P. Steg,et al.  Impact of Prehospital Thrombolysis for Acute Myocardial Infarction on 1-Year Outcome: Results From the French Nationwide USIC 2000 Registry , 2004, Circulation.

[480]  P. Steen,et al.  Long-term prognosis after out-of-hospital cardiac arrest and primary percutaneous coronary intervention. , 2004, Resuscitation.

[481]  O. Penn,et al.  Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[482]  Holly Rimmasch,et al.  Improvements in 1-Year Cardiovascular Clinical Outcomes Associated with a Hospital-Based Discharge Medication Program , 2004, Annals of Internal Medicine.

[483]  F. Fernández‐Avilés,et al.  Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial , 2004, The Lancet.

[484]  M. Pfeffer,et al.  Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. , 2004, JAMA.

[485]  Mohamud Daya,et al.  Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. , 2004, Journal of the American College of Cardiology.

[486]  J. Ottervanger,et al.  Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. , 2004, American heart journal.

[487]  C. W. Barth,et al.  Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. , 2004, American heart journal.

[488]  Lippincott Williams Wilkins,et al.  ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2004 .

[489]  Christopher P Cannon,et al.  Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.

[490]  J P Ornato,et al.  Public-access Defibrillation and Survival after Out-of-hospital Cardiac Arrest Recommended Citation Public-access Defibrillation and Survival after Out-of-hospital Cardiac Arrest , 2022 .

[491]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[492]  H. Diener,et al.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[493]  M. de Belder,et al.  A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. , 2004, Journal of the American College of Cardiology.

[494]  G. Montalescot,et al.  Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis. , 2004, JAMA.

[495]  G. Biondi-Zoccai,et al.  Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. , 2004, Journal of the American College of Cardiology.

[496]  A. Toso,et al.  Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[497]  S. Ebrahim,et al.  Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. , 2004, The American journal of medicine.

[498]  J. T. ten Berg,et al.  Primary stenting of occluded native coronary arteries: final results of the Primary Stenting of Occluded Native Coronary Arteries (PRISON) study. , 2004, American heart journal.

[499]  I. Piña.  Valsartan in acute myocardial infarction trial. , 2004, Current cardiology reports.

[500]  David J Cohen,et al.  Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation , 2004, Circulation.

[501]  E. Topol,et al.  Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial. , 2004, American heart journal.

[502]  Elliott M. Antman,et al.  Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction: Every Minute of Delay Counts , 2004, Circulation.

[503]  T. Harr,et al.  Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials. , 2004, The American journal of medicine.

[504]  N. Wenger.  You've come a long way, baby: cardiovascular health and disease in women: problems and prospects. , 2004, Circulation.

[505]  Constance K Haan,et al.  Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women , 2004, Circulation.

[506]  A. Cohen-Solal,et al.  Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes: Observations From the Global Registry of Acute Coronary Events (GRACE) , 2004, Circulation.

[507]  M. Müllner,et al.  Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. , 2004, JAMA.

[508]  G. Stone,et al.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.

[509]  H. Hanley,et al.  Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[510]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[511]  J. Jui,et al.  Patients with chest pain calling 9-1-1 or self-transporting to reach definitive care: which mode is quicker? , 2004, American heart journal.

[512]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[513]  F. Eberli,et al.  Early exercise after coronary stenting is safe. , 2003, Journal of the American College of Cardiology.

[514]  S. Assmann,et al.  Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial. , 2003, American heart journal.

[515]  S. Jaglal,et al.  Evaluation of a community-based inner-city disease management program for postmyocardial infarction patients: a randomized controlled trial. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[516]  M. Dalby,et al.  Transfer for Primary Angioplasty Versus Immediate Thrombolysis in Acute Myocardial Infarction: A Meta-Analysis , 2003, Circulation.

[517]  P. Greenland,et al.  Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. , 2003, Archives of internal medicine.

[518]  M. Grzybowski,et al.  Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis. , 2003, JAMA.

[519]  B. Nallamothu,et al.  Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? , 2003, The American journal of cardiology.

[520]  A. Kastrati,et al.  Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[521]  E. Antman,et al.  ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.

[522]  E. Antman,et al.  ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.

[523]  Pamela S Douglas,et al.  Acc/aha/ase 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article a Report of the American College of Cardiology/american Heart Association Task Force on Practice Guidelines (acc/aha/ase Committee to Update the 1997 Guidelines for the Clinical Application of Echocar , 2003 .

[524]  D. Faxon,et al.  ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca , 2003, Journal of the American College of Cardiology.

[525]  Felix Zijlstra,et al.  Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. , 2003, Journal of the American College of Cardiology.

[526]  P. Janský,et al.  International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2. , 2003, European heart journal.

[527]  Masood Ahmad,et al.  Ventricular free wall rupture following acute myocardial infarction. , 2003, Coronary artery disease.

[528]  E. Ohman,et al.  Relation Between Hospital Intra-Aortic Balloon Counterpulsation Volume and Mortality in Acute Myocardial Infarction Complicated by Cardiogenic Shock , 2003, Circulation.

[529]  Klaus Rasmussen,et al.  A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. , 2003, The New England journal of medicine.

[530]  C. Hofer,et al.  Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[531]  J. Soler‐Soler,et al.  Prognostic Value of Lead aVR in Patients With a First Non–ST-Segment Elevation Acute Myocardial Infarction , 2003, Circulation.

[532]  T. Nielsen,et al.  Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). , 2003, American heart journal.

[533]  H. Krumholz,et al.  Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[534]  A. Favero,et al.  Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics , 2003, BMJ : British Medical Journal.

[535]  E. Antman,et al.  Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. , 2003, Journal of the American College of Cardiology.

[536]  T. Ryan,et al.  Outcomes of percutaneous coronary intervention among elderly patients in cardiogenic shock: a multicenter, decade-long experience. , 2003, The Journal of invasive cardiology.

[537]  Roger D. White,et al.  Early direct coronary angioplasty in survivors of out-of-hospital cardiac arrest. , 2003, The American journal of cardiology.

[538]  Deepak L. Bhatt,et al.  Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. , 2003, Archives of internal medicine.

[539]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[540]  L. Sleeper,et al.  Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry , 2003 .

[541]  C. Thomson,et al.  Hospital- and clinic-based smoking cessation interventions for smokers with cardiovascular disease. , 2003, Progress in cardiovascular diseases.

[542]  C. Terkelsen,et al.  Are we underestimating the full potential of early thrombolytic treatment in patients with acute myocardial infarction? , 2003, Heart.

[543]  S. Kelsey,et al.  Modeling and Risk Prediction in the Current Era of Interventional Cardiology: A Report From the National Heart, Lung, and Blood Institute Dynamic Registry , 2003, Circulation.

[544]  V. Hombach,et al.  Reduction of Major Adverse Cardiac Events With Intracoronary Compared With Intravenous Bolus Application of Abciximab in Patients With Acute Myocardial Infarction or Unstable Angina Undergoing Coronary Angioplasty , 2003, Circulation.

[545]  B. Pitt,et al.  Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[546]  C. Boult,et al.  Improving the Quality of Transitional Care for Persons with Complex Care Needs , 2003, Journal of the American Geriatrics Society.

[547]  Jeroen J. Bax,et al.  Impact of percutaneous coronary intervention or coronary artery bypass grafting on outcome after nonfatal cardiac arrest outside the hospital. , 2003, The American journal of cardiology.

[548]  E. Coleman.  Falling Through the Cracks: Challenges and Opportunities for Improving Transitional Care for Persons with Continuous Complex Care Needs , 2003, Journal of the American Geriatrics Society.

[549]  E. Topol,et al.  Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. , 2003, JAMA.

[550]  Mohamud Daya,et al.  The Public Access Defibrillation (PAD) trial: study design and rationale. , 2003, Resuscitation.

[551]  Sankey V. Williams,et al.  ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.

[552]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .

[553]  M. Aschermann,et al.  Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2. , 2003, European heart journal.

[554]  Y. Woo,et al.  Off-pump coronary artery bypass grafting attenuates postoperative bleeding associated with preoperative clopidogrel administration. , 2003, The heart surgery forum.

[555]  V. Hasselblad,et al.  Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making. , 2003, European heart journal.

[556]  William J. Rogers,et al.  Use of Emergency Medical Services in Acute Myocardial Infarction and Subsequent Quality of Care: Observations From the National Registry of Myocardial Infarction 2 , 2002, Circulation.

[557]  K. Takazawa,et al.  Correlation between thallium-201 myocardial perfusion defects and the functional severity of coronary artery stenosis as assessed by pressure-derived myocardial fractional flow reserve. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[558]  Eric J Topol,et al.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[559]  R. Califf,et al.  Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. , 2002, JAMA.

[560]  E. Antman,et al.  Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration. , 2002, American heart journal.

[561]  G. Lip,et al.  ABC of antithrombotic therapy: Venous thromboembolism: pathophysiology, clinical features, and prevention , 2002 .

[562]  G. Lip,et al.  Venous thromboembolism: pathophysiology, clinical features, and prevention , 2002, BMJ : British Medical Journal.

[563]  Lance B Becker,et al.  Public use of automated external defibrillators. , 2002, The New England journal of medicine.

[564]  L. Parsons,et al.  Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). , 2002, Journal of the American College of Cardiology.

[565]  P. Serruys,et al.  Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction. , 2002, European heart journal.

[566]  E. Antman,et al.  ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). , 2002, Journal of the American College of Cardiology.

[567]  M. Mcclellan,et al.  Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.

[568]  P. Touboul,et al.  Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study , 2002, The Lancet.

[569]  K. Dickstein,et al.  Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial , 2002, The Lancet.

[570]  S. Lai,et al.  Impact of Community-Wide Police Car Deployment of Automated External Defibrillators on Survival From Out-of-Hospital Cardiac Arrest , 2002, Circulation.

[571]  C. Di Mario,et al.  Results and Long-Term Predictors of Adverse Clinical Events After Elective Percutaneous Interventions on Unprotected Left Main Coronary Artery , 2002, Circulation.

[572]  J. Cortadellas,et al.  Nature and progression of pericardial effusion in patients with a first myocardial infarction: relationship to age and free wall rupture. , 2002, American heart journal.

[573]  R. Hongo,et al.  The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting , 2002 .

[574]  R. Hongo,et al.  The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. , 2002, Journal of the American College of Cardiology.

[575]  E. Antman,et al.  Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. , 2002, Journal of the American College of Cardiology.

[576]  D. Zipes,et al.  Attitudes of law enforcement officers regarding automated external defibrillators. , 2002, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[577]  L. Wallentin,et al.  Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study , 2002, The Lancet.

[578]  C. Lamendola,et al.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. , 2002, Circulation.

[579]  E. Braunwald,et al.  Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic Administration in Acute Myocardial Infarction , 2002, Circulation.

[580]  H. Heidbuchel,et al.  Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial , 2002, Circulation.

[581]  David Brieger,et al.  Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry). , 2002, The American journal of cardiology.

[582]  J. J. Griffin,et al.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.

[583]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[584]  A. Connor,et al.  The way I see it: House officers need formal career development , 2002 .

[585]  Michael Holzer,et al.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest , 2002 .

[586]  S. Bernard,et al.  Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. , 2002, The New England journal of medicine.

[587]  J. Tijssen,et al.  Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis. , 2002, The American journal of cardiology.

[588]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[589]  R. Califf,et al.  Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials , 2002, The Lancet.

[590]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[591]  C. Piot,et al.  QRS and Cycle Length Alternans During Paroxysmal Supraventricular Tachycardia: What is the Mechanism? , 2002, Journal of cardiovascular electrophysiology.

[592]  R. Koster.  Automatic External Defibrillator: Key Link in the Chain of Survival , 2002, Journal of cardiovascular electrophysiology.

[593]  Joseph P Ornato,et al.  L AW E NFORCEMENT A GENCY D EFIBRILLATION (LEA-D): P ROCEEDINGS OF THE N ATIONAL C ENTER FOR E ARLY D EFIBRILLATION P OLICE AED I SSUES F ORUM , 2002, Resuscitation.

[594]  K. Coyne,et al.  Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin Second Trial of Heparin and Aspirin Reperfusion Therapy (HART II) , 2002 .

[595]  J. Monro,et al.  Mitral valve surgery for acute papillary muscle rupture following myocardial infarction. , 2002, The Journal of heart valve disease.

[596]  M. Turina,et al.  Surgical management of acute mitral valve regurgitation due to post-infarction papillary muscle rupture. , 2002, The Journal of heart valve disease.

[597]  Malbea A Lapete,et al.  Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2004 .

[598]  S. Scolletta,et al.  Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting. , 2001, The Journal of thoracic and cardiovascular surgery.

[599]  R. Wunderink,et al.  Effect of clopidogrel on bleeding after coronary artery bypass surgery , 2001, Critical care medicine.

[600]  H. White,et al.  Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial , 2001, The Lancet.

[601]  Seung‐Jung Park,et al.  Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. , 2001, Journal of the American College of Cardiology.

[602]  C Lenfant,et al.  Timing is everything: motivating patients to call 9-1-1 at onset of acute myocardial infarction. , 2001, Circulation.

[603]  Assent investigators.  Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction , 2001, The Lancet.

[604]  Salim Yusuf,et al.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study , 2001, The Lancet.

[605]  L. Clark,et al.  Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials. , 2001, The American journal of cardiology.

[606]  E. Antman,et al.  Bolus fibrinolytic therapy in acute myocardial infarction. , 2001, JAMA.

[607]  M. Morice,et al.  Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. , 2001, The New England journal of medicine.

[608]  P. Armstrong,et al.  Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1. , 2001, Circulation.

[609]  S. Hindman,et al.  Surgical experience with left ventricular free wall rupture. , 2001, The Annals of thoracic surgery.

[610]  J. Gore,et al.  The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. , 2001, American heart journal.

[611]  K. Bailey,et al.  Infarct artery reocclusion after primary angioplasty, stent placement, and thrombolytic therapy for acute myocardial infarction. , 2001, American heart journal.

[612]  K. Wegscheider,et al.  Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial. , 2001, European heart journal.

[613]  Michael F. Oliver,et al.  Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study. , 2001, Indian heart journal.

[614]  J. Gore,et al.  Outcomes and early revascularization for patients > or = 65 years of age with cardiogenic shock. , 2001, The American journal of cardiology.

[615]  T. Brennan,et al.  Delay in seeking emergency care. , 2001, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[616]  J. Ornato,et al.  Factors associated with the occurrence of cardiac arrest during hospitalization for acute myocardial infarction in the second national registry of myocardial infarction in the US. , 2001, Resuscitation.

[617]  H. White,et al.  One-year survival following early revascularization for cardiogenic shock. , 2001, JAMA.

[618]  P. R. R. Ecurrent,et al.  EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .

[619]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[620]  S. Yusuf,et al.  The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. , 2000, European heart journal.

[621]  Hideyuki Shitaka.  From Paradise Lost to Paradise Regained , 2000 .

[622]  D K McKenas,et al.  Use of automated external defibrillators by a U.S. airline. , 2000, The New England journal of medicine.

[623]  D J Roe,et al.  Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. , 2000, The New England journal of medicine.

[624]  E. Antman,et al.  TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy , 2000, Circulation.

[625]  F. Verheugt,et al.  Successful out-of-hospital cardiopulmonary resuscitation: what is the optimal in-hospital treatment strategy? , 2000, Resuscitation.

[626]  W. O’Neill,et al.  Multiple complex coronary plaques in patients with acute myocardial infarction. , 2000, The New England journal of medicine.

[627]  L. Leviton,et al.  Patient delay in seeking care for heart attack symptoms: findings from focus groups conducted in five U.S. regions. , 2000, Preventive medicine.

[628]  R. Harrington,et al.  Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy. , 2000, The Annals of thoracic surgery.

[629]  H. White,et al.  Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[630]  A. Jacobs,et al.  Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction : A report from the shock trial Registry , 2000 .

[631]  L. Sleeper,et al.  Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[632]  J. Hochman,et al.  Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? , 2000, Journal of the American College of Cardiology.

[633]  L. Sleeper,et al.  Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[634]  F Van de Werf,et al.  Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. , 2000, The New England journal of medicine.

[635]  I. Piña,et al.  Core components of cardiac rehabilitation/secondary prevention programs: A statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation Writing Group. , 2000, Circulation.

[636]  R. Gibbons,et al.  The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction , 2000, Heart.

[637]  M. de Belder,et al.  Failure of thrombolysis by streptokinase: detection with a simple electrocardiographic method , 2000, Heart.

[638]  C. Morrison,et al.  Delay in calling for help during myocardial infarction: reasons for the delay and subsequent pattern of accessing care , 2000, Heart.

[639]  Adam Brown,et al.  Demographic, belief, and situational factors influencing the decision to utilize emergency medical services among chest pain patients. Rapid Early Action for Coronary Treatment (REACT) study. , 2000, Circulation.

[640]  H A Feldman,et al.  Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. , 2000, JAMA.

[641]  D. Moser,et al.  Treatment-seeking behavior for acute myocardial infarction symptoms in North America and Australia. , 2000, Heart & lung : the journal of critical care.

[642]  B. Gersh,et al.  The case for an aggressive surgical approach to papillary muscle rupture following myocardial infarction: “From paradise lost to paradise regained” , 2000, Heart.

[643]  L. Morrison,et al.  Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. , 2000, JAMA.

[644]  D. Cook,et al.  Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. , 2000, Archives of internal medicine.

[645]  A. Raizner,et al.  Catastrophic outcomes of noncardiac surgery soon after coronary stenting. , 2000, Journal of the American College of Cardiology.

[646]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[647]  E. Antman,et al.  The length of the hospital stay after myocardial infarction. , 2000, The New England journal of medicine.

[648]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[649]  R. Fasol,et al.  Mitral repair in patients with a ruptured papillary muscle. , 2000, American heart journal.

[650]  E. Antman,et al.  ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators. , 2000, The American journal of cardiology.

[651]  J. Douketis,et al.  A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. , 2000, Archives of internal medicine.

[652]  R. Califf,et al.  Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. , 2000, Circulation.

[653]  A. Oktay,et al.  Correlation of myocardial fractional flow reserve with thallium-201 SPECT imaging in intermediate-severity coronary artery lesions. , 1999, The Journal of invasive cardiology.

[654]  S. Osganian,et al.  Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Rapid Early Action for Coronary Treatment (REACT) Study Group. , 1999, American heart journal.

[655]  J. Ottervanger,et al.  Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. , 1999, The New England journal of medicine.

[656]  M. Lachat,et al.  Operative results of "repair" of ventricular septal rupture after acute myocardial infraction. , 1999, The American journal of cardiology.

[657]  F. Werf.  Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial , 1999, The Lancet.

[658]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[659]  C. Herzog.  Acute myocardial infarction in patients with end-stage renal disease. , 1999, Kidney international. Supplement.

[660]  Nick Freemantle,et al.  β Blockade after myocardial infarction: systematic review and meta regression analysis , 1999 .

[661]  H Wedel,et al.  Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .

[662]  E. Braunwald,et al.  Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. , 1999, Circulation.

[663]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[664]  H. Wellens,et al.  The value of the right precordial leads of the electrocardiogram. , 1999, The New England journal of medicine.

[665]  R. Schiele,et al.  Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[666]  S. Kaul,et al.  Writing Group Members , 2022 .

[667]  S. Kaul,et al.  ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. , 1999, Journal of the American College of Cardiology.

[668]  R. Califf,et al.  Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. , 1998, Circulation.

[669]  Roger D. White,et al.  Seven years' experience with early defibrillation by police and paramedics in an emergency medical services system. , 1998, Resuscitation.

[670]  R. Califf,et al.  Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial. , 1998, Journal of the American College of Cardiology.

[671]  J. Ornato,et al.  Bundle-Branch Block and In-Hospital Mortality in Acute Myocardial Infarction , 1998, Annals of Internal Medicine.

[672]  J. Burchenal,et al.  Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial Infarction , 1998 .

[673]  H A Feldman,et al.  Statistical design of REACT (Rapid Early Action for Coronary Treatment), a multisite community trial with continual data collection. , 1998, Controlled clinical trials.

[674]  R. Beyth,et al.  Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. , 1998, The American journal of medicine.

[675]  R. Collins,et al.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.

[676]  C. Ho,et al.  Response times and outcomes for cardiac arrests in Las Vegas casinos. , 1998, The American journal of emergency medicine.

[677]  R. Gibbons,et al.  Time to therapy and salvage in myocardial infarction. , 1998, Journal of the American College of Cardiology.

[678]  S. Langley,et al.  Should coronary artery bypass grafting be performed at the same time as repair of a post-infarct ventricular septal defect? , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[679]  W. Wijns,et al.  Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. , 1998, Journal of the American College of Cardiology.

[680]  A. U. Rickel,et al.  Guidelines for Prevention, I , 1998 .

[681]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[682]  D J Roe,et al.  Estimating effectiveness of cardiac arrest interventions: a logistic regression survival model. , 1997, Circulation.

[683]  M. Farrer,et al.  Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes , 1997, Heart.

[684]  H. Arendrup,et al.  Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. , 1997, Circulation.

[685]  S. Solomon,et al.  Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. , 1997, Circulation.

[686]  M. Simoons,et al.  A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. , 1997, The New England journal of medicine.

[687]  J. Dhainaut,et al.  Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. , 1997, The New England journal of medicine.

[688]  J. Ornato,et al.  The Physician's Role in Minimizing Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction: Recommendations from the National Heart Attack Alert Program , 1997, Annals of Internal Medicine.

[689]  T. Investigators,et al.  A comparison of reteplase with alteplase for acute myocardial infarction , 1997 .

[690]  R. Califf,et al.  Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. , 1997, Circulation.

[691]  E. Braunwald,et al.  TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. , 1997, Circulation.

[692]  A. Hall,et al.  Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. , 1997, European heart journal.

[693]  M. P. Larsen,et al.  Incidence of cardiac arrest during self-transport for chest pain. , 1996, Annals of emergency medicine.

[694]  M. Krucoff,et al.  Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy. , 1996, Circulation.

[695]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[696]  Eric Boersma,et al.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour , 1996, The Lancet.

[697]  R. Califf,et al.  One-Year Results From the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) Trial , 1996 .

[698]  W. Weaver,et al.  Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. , 1996, Circulation.

[699]  J. Pearn,et al.  First aid in the air. , 1996, The Australian and New Zealand journal of surgery.

[700]  P. H. van der Voort,et al.  Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.

[701]  F Van de Werf,et al.  Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. , 1996, Journal of the American College of Cardiology.

[702]  R. M. Rubison,et al.  A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. , 1996, Journal of the American College of Cardiology.

[703]  A. Skene,et al.  Late assessment of thrombolytic efficacy (LATE) study: Prognosis in patients with non-Q wave myocardial infarction , 1996 .

[704]  M. Hadamitzky,et al.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. , 1996, The New England journal of medicine.

[705]  K. Lee,et al.  Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. , 1996, Circulation.

[706]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[707]  K Wegscheider,et al.  Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. , 1995, Journal of the American College of Cardiology.

[708]  R. Myerburg,et al.  ST segment tracking for rapid determination of patency of the infarct-related artery in acute myocardial infarction. , 1995, Journal of the American College of Cardiology.

[709]  B. Psaty,et al.  Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. , 1995, Circulation.

[710]  A. Maggioni,et al.  Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base , 1995, The Lancet.

[711]  R. Swor,et al.  Primary coronary angioplasty for acute myocardial infarction complicated by out-of-hospital cardiac arrest. , 1995, American Journal of Cardiology.

[712]  B. Chaitman,et al.  Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. , 1995, Circulation.

[713]  H. Crijns,et al.  Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. , 1995, Circulation.

[714]  Raymond C. Schneider,et al.  ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.

[715]  C. Fry,et al.  Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.

[716]  M. Naylor,et al.  Comprehensive Discharge Planning for the Hospitalized Elderly , 1994, Annals of Internal Medicine.

[717]  J. Stengård,et al.  Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.

[718]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction , 1994, The Lancet.

[719]  S. Ball,et al.  ACE inhibition, atherosclerosis and myocardial infarction--the AIRE Study in practice. Acute Infarction Ramipril Efficacy Study. , 1994, European heart journal.

[720]  J. W. Kinch,et al.  Right ventricular infarction. , 1994, The New England journal of medicine.

[721]  K. Kuck,et al.  Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). , 1994, American heart journal.

[722]  Fibrinolytictherapytrialistsf.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[723]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[724]  D. Orsinelli,et al.  Usefulness of transesophageal echocardiography to screen for left atrial thrombus before elective cardioversion for atrial fibrillation. , 1993, The American journal of cardiology.

[725]  R. O'rourke,et al.  Comparison of symptom-limited and low level exercise tolerance tests early after myocardial infarction. , 1993, Journal of the American College of Cardiology.

[726]  Gusto Angiographic Investigators.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[727]  A. Hallstrom,et al.  Predicting survival from out-of-hospital cardiac arrest: a graphic model. , 1993, Annals of emergency medicine.

[728]  P. Kudenchuk,et al.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. , 1993, JAMA.

[729]  U. Tebbe,et al.  Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. , 1993, Journal of the American College of Cardiology.

[730]  L. Wilkins.  Early Effects of Tissue‐Type Plasminogen Activator Added to Conventional Therapy on the Culprit Coronary Lesion in Patients Presenting With Ischemic Cardiac Pain at Rest Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trialx , 1993, Circulation.

[731]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[732]  S. Westaby,et al.  Thrombolysis and postinfarction ventricular septal rupture. , 1992, The Journal of thoracic and cardiovascular surgery.

[733]  O. Topaz,et al.  Interventricular septal rupture complicating acute myocardial infarction: from pathophysiologic features to the role of invasive and noninvasive diagnostic modalities in current management. , 1992, The American journal of medicine.

[734]  S. Smith,et al.  Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease. , 1992, American heart journal.

[735]  W. Daggett,et al.  Postinfarct ventricular septal defect repair: effect of coronary artery bypass grafting. , 1992, The Annals of thoracic surgery.

[736]  A. Tajik,et al.  Mitral valve operation in postinfarction rupture of a papillary muscle: immediate results and long-term follow-up of 22 patients. , 1992, Mayo Clinic proceedings.

[737]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[738]  B. Gersh,et al.  Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. , 1992, The American journal of cardiology.

[739]  U. Tebbe,et al.  Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS) , 1992, Journal of the American College of Cardiology.

[740]  P. Eisenberg.  Role of heparin in coronary thrombolysis. , 1992, Chest.

[741]  David Hunt,et al.  ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION , 1992 .

[742]  M. Pfisterer,et al.  Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial. , 1992, British heart journal.

[743]  P Rossi,et al.  Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction. Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group. , 1991, The American journal of cardiology.

[744]  J. Ornato,et al.  Improving survival from sudden cardiac arrest: the "chain of survival" concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association. , 1991, Circulation.

[745]  A. Tonkin,et al.  A Randomized Comparison of Intravenous Heparin With Oral Aspirin and Dipyridamole 24 Hours After Recombinant Tissue‐Type Plasminogen Activator for Acute Myocardial Infarction , 1991, Circulation.

[746]  K. Lee,et al.  Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. , 1991, American heart journal.

[747]  W. Rogers,et al.  Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. , 1991, Circulation.

[748]  J. Ornato,et al.  Improving survival from sudden cardiac arrest , 1991 .

[749]  F. Sheehan,et al.  Prehospital thrombolysis in acute myocardial infarction. , 1990, The American journal of cardiology.

[750]  R. Califf,et al.  Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage. The TAMI Study Group. , 1990, The American journal of cardiology.

[751]  F. Harrell,et al.  Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. , 1990, Journal of the American College of Cardiology.

[752]  J. Monro,et al.  Surgical treatment for infarct-related ventricular septal defects. Improved early results combined with analysis of late functional status. , 1990, The Journal of thoracic and cardiovascular surgery.

[753]  H. Hod,et al.  Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. , 1990, Journal of the American College of Cardiology.

[754]  C. Furberg,et al.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. , 1989, BMJ.

[755]  A. Castaigne,et al.  Prehospital use of APSAC: results of a placebo-controlled study. , 1989, The American journal of cardiology.

[756]  E. Salcedo,et al.  Electrocardiographic manifestations of right ventricular infarction. , 1989, American heart journal.

[757]  A. M. Skene,et al.  TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.

[758]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[759]  F. Sheehan,et al.  Intravenous streptokinase for acute myocardial infarction. Effects on global and regional systolic function. , 1988, Circulation.

[760]  Lynne H. Taylor,et al.  Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. , 1987, Circulation.

[761]  Dwight Lemon,et al.  Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 , 1987 .

[762]  H. Silverman,et al.  Relation between use of anti-inflammatory agents and left ventricular free wall rupture during acute myocardial infarction. , 1987, The American journal of cardiology.

[763]  A. Alonzo,et al.  The impact of the family and lay others on care-seeking during life-threatening episodes of suspected coronary artery disease. , 1986, Social science & medicine.

[764]  L. Edmunds,et al.  Operation for acute postinfarction mitral insufficiency and cardiogenic shock. , 1985, The Journal of thoracic and cardiovascular surgery.

[765]  E. Falk.  Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.

[766]  M J Davies,et al.  Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.

[767]  J. Leppo,et al.  Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. , 1984, The New England journal of medicine.

[768]  J. Alpert,et al.  Therapy of symptomatic pericarditis after myocardial infarction: retrospective and prospective studies of aspirin, indomethacin, prednisone, and spontaneous resolution. , 1981, American heart journal.

[769]  D. Waters,et al.  Prognostic value of exercise testing soon after myocardial infarction. , 1979, The New England journal of medicine.

[770]  T. Waterston.  FLUIDS FOR DIARRHŒA IN YOUNG CHILDREN , 1977, The Lancet.

[771]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .

[772]  W. Roberts,et al.  Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm. , 1974, The American journal of medicine.

[773]  Barr Jb,et al.  HOME OR AWAY , 1964 .